PRECISION BIOSCIENCES INC — Director's Dealing 2020

Jun 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2020-06-08

Reporting Person: Heery Christopher (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-08	Employee Stock Option (Right to Buy)	$8.21	A	133206	Acquired	2030-06-07	Common Stock (133206)	Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.